10x Genomics gets injunction against Parse Biosciences' ATAC Products
According to the company, this injunction bars Parse from making, using, selling, or offering for sale its planned ATAC and ...
Nasdaq15d
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
selling or offering for sale its planned ATAC and ATAC-Multiome Single Cell products. As part of this consent agreement, Parse admitted that 10x's ATAC-seq patents are valid, enforceable and ...